GIP

Retatrutide

Note: Peptides will arrive in a lyophilized (powder) form for maximum stability. Retatrutide is a next-generation peptide designed to target three key hormone receptors in the body—GLP-1, GIP, and glucagon receptors—simultaneously. By combining the benefits of appetite suppression, increased calorie burning, and enhanced insulin sensitivity, Retatrutide has demonstrated exceptional potential in research focused on obesity, type 2 diabetes, and metabolic liver conditions. In clinical studies, participants experienced profound weight loss and improved metabolic health, making it one of the most promising research compounds under investigation for full-spectrum metabolic support¹²³.